Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Shan Dong Kexing Bioproducts Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥-66 Mil. Shan Dong Kexing Bioproducts Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥-10 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Shan Dong Kexing Bioproducts Co's Interest Coverage or its related term are showing as below:
SHSE:688136's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 105.09 * Ranked among companies with meaningful Interest Coverage only.
Shan Dong Kexing Bioproducts Co (SHSE:688136) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shan Dong Kexing Bioproducts Co Interest Coverage Related Terms
Shan Dong Kexing Bioproducts Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Shan Dong Kexing Bioproducts Co Interest Coverage Chart
SHSE:688136 vs VRTX, REGN, RVMD: Interest Coverage Comparison
For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shan Dong Kexing Bioproducts Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Interest Coverage falls into.
Shan Dong Kexing Bioproducts Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Shan Dong Kexing Bioproducts Co did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a Interest Coverage of 0 (At Loss) as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. According to the industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #999999 out of 378 companies in the Biotechnology industry.
Is Shan Dong Kexing Bioproducts Co's Interest Coverage too high?
Shan Dong Kexing Bioproducts Co's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Shan Dong Kexing Bioproducts Co ranks #999999 out of 378 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #999999 out of 378 companies for Interest Coverage. This places Shan Dong Kexing Bioproducts Co in the lower half of its industry. The industry median Interest Coverage is 105.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 105.09, based on 378 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 105.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shan Dong Kexing Bioproducts Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Fairly Valued. The stock's GF Value™ is ¥23.02, compared to a current price of ¥22.60 — trading 1.8% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Shan Dong Kexing Bioproducts Co's overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current Interest Coverage is 0 (At Loss) as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued.
The current stock price of ¥22.60 is trading 1.8% below its estimated GF Value™ of ¥23.02.
GuruFocus considers Shan Dong Kexing Bioproducts Co to be Fairly Valued.
Key valuation signals for SHSE:688136:
Interest Coverage: 0 (At Loss)
GF Value™: ¥23.02 vs. price of ¥22.60 (1.8% below fair value)
No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
45GF Score
Get the complete analysis for SHSE:688136
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688136 has been successfully added to your 
